Literature DB >> 17272212

Septic shock after conservative management for placenta accreta.

Ying-Cheng Chiang1, Jin-Chung Shih, Chien-Nan Lee.   

Abstract

OBJECTIVE: The rate of placenta accreta has risen in the last three decades due to the increasing rate of cesarean section. Placenta accreta usually results in severe postpartum hemorrhage requiring massive blood transfusion and postpartum hysterectomy. Conservative treatment is an alternative in selected patients to preserve fertility and decrease postpartum hemorrhage, but the risks of conservative treatment have seldom been described. CASE REPORT: A 39-year-old woman with placenta accreta diagnosed during cesarean section was treated conservatively. Persistent puerperal fever with leukocytosis developed during the postpartum period in spite of long-term antibiotic treatment. Evacuation of the retained placenta resulted in septic shock, which occurred immediately after dilatation and curettage. An uneventful recovery was achieved after use of strong antibiotics and fluid challenge.
CONCLUSION: At present, there is no consensus about the optimal treatment for placenta accreta. Conservative treatment appears to be an alternative in selected patients, but the complications such as sepsis should be carefully identified and appropriately managed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17272212     DOI: 10.1016/S1028-4559(09)60194-7

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  2 in total

Review 1.  Invasive placentation and uterus preserving treatment modalities: a systematic review.

Authors:  Charlotte N Steins Bisschop; Timme P Schaap; Tatjana E Vogelvang; Piet C Scholten
Journal:  Arch Gynecol Obstet       Date:  2011-06-03       Impact factor: 2.344

2.  Clinical aspects and antenatal diagnosis of invasive placenta: a review of ten-years' experience of a multi-profile hospital in Lithuania.

Authors:  Jelena Volochovič; Diana Ramašauskaitė; Ramunė Šimkevičiūtė
Journal:  Acta Med Litu       Date:  2017
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.